News and Views
Nature Medicine 14, 715 - 716 (2008)
doi:10.1038/nm0708-715
Chipping away at gallstones
Folkert Kuipers1 & Albert K Groen2
- Folkert Kuipers is at the Departments of Pediatrics and Laboratory Medicine, Center for Liver Digestive and Metabolic Diseases, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
- Albert K. Groen is at the Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands. e-mail: f.kuipers@med.umcg.nl or e-mail: a.k.groen@uva.amc.nl
Abstract
Gallstone disease occurs more frequently in subjects with the metabolic syndrome and type 2 diabetes. Findings in a mouse model suggest that the forkhead transcription factor FoxO1 lies behind this association (pages 778–782).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Prevention of cholesterol gallstone disease by FXR agonists in a mouse modelNature Medicine Article (01 Dec 2004)
Hepatic insulin resistance directly promotes formation of cholesterol gallstonesNature Medicine Letter (01 Jul 2008)
See all 4 matches for Research
